Soumit Roy – Jones Trading

Jones Trading

A Jones Trading analyst with 30 tracked ratings covering 26 distinct tickers has a 30% success rate on the captured sample, focusing on sectors represented in 10 ratings across two sources.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

2 months ago

2026-03-10 00:00:00+00

Track record

Aggregated

30% success rate

Bullish: 0
Hold: 0
Bearish: 0

Aggregated

Not available

Bullish: 15
Hold: 5
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
EDIT	2026-03-10	buy	$8.00	Aggregated
CNTX	2025-12-22	buy	$7.00	Aggregated
WHWK	2025-12-22	buy	$7.00	Aggregated
AVXL	2025-10-24	hold	-	Aggregated
CGON	2025-09-08	buy	$50.00	Aggregated
TARA	2025-05-22	buy	$21.00	Aggregated
AVBP	2025-05-20	buy	$40.00	Aggregated
AVBPARRIVENT BIOPHARMA INC.	2025-05-20	unknown	$40.00	Aggregated
ACRV	2025-05-16	hold	-	Aggregated
ELVN	2025-05-16	buy	$27.00	Aggregated
ONCY	2025-05-16	hold	-	Aggregated
NUVBNUVATION BIO INC - ORDINARY SHARES - CLASS A	2025-03-12	unknown	$10.00	Aggregated
BEAM	2025-03-10	buy	$34.00	Aggregated
BEAMBEAM THERAPEUTICS INC	2025-03-10	unknown	$34.00	Aggregated
INAB	2025-02-11	buy	$1.20	Aggregated
OKUR	2025-01-28	buy	$32.00	Aggregated
OKURONKURE THERAPEUTICS, INC. CLASS A COMMON STOCK	2025-01-28	unknown	$32.00	Aggregated
ELTX	2024-10-31	buy	$9.00	Aggregated
ELTXELICIO THERAPEUTICS INC.	2024-10-31	unknown	$9.00	Aggregated
ELVN	2024-10-31	buy	$36.00	Aggregated
ELVNENLIVEN THERAPEUTICS INC	2024-10-31	unknown	$36.00	Aggregated
ORICORIC PHARMACEUTICALS INC	2024-10-31	unknown	$17.00	Aggregated
EDIT	2024-09-17	buy	$13.00	Aggregated
EDITEDITAS MEDICINE INC	2024-09-17	unknown	$13.00	Aggregated
ACET	2024-09-11	buy	$4.00	Aggregated
ACETADICET BIO INC	2024-09-11	unknown	$4.00	Aggregated
INAB	2024-08-12	hold	-	Aggregated
INAB	2024-06-14	buy	$6.50	Aggregated
CRVOCERVOMED INC	2024-05-29	unknown	$70.00	Aggregated
BOLT	2024-05-15	hold	-	Aggregated
CGEMCULLINAN THERAPEUTICS INC	2024-04-17	unknown	$26.00	Aggregated
JANXJANUX THERAPEUTICS INC	2024-04-16	unknown	$70.00	Aggregated
MNPRMONOPAR THERAPEUTICS INC	2024-04-11	unknown	$2.00	Aggregated
INABIN8BIO INC	2024-03-13	unknown	$5.00	Aggregated
ONCYONCOLYTICS BIOTECH, INC.	2023-05-24	unknown	$9.00	Aggregated
COEPCOEPTIS THERAPEUTICS HOLDINGS INC	2023-04-19	unknown	$4.00	Aggregated
HCWBHCW BIOLOGICS INC	2022-11-08	unknown	$8.00	Aggregated
RAINRAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. CLASS A COMMON STOCK	2022-06-23	unknown	$17.00	Aggregated

Tickers covered(34)

Ticker	Ratings	Last rating	Sources
EDIT	2	2026-03-10	Aggregated
CNTX	1	2025-12-22	Aggregated
WHWK	1	2025-12-22	Aggregated
AVXL	1	2025-10-24	Aggregated
CGON	1	2025-09-08	Aggregated
TARA	1	2025-05-22	Aggregated
AVBP	1	2025-05-20	Aggregated
AVBPARRIVENT BIOPHARMA INC.	1	2025-05-20	Aggregated
ACRV	1	2025-05-16	Aggregated
ELVN	2	2025-05-16	Aggregated
ONCY	1	2025-05-16	Aggregated
NUVBNUVATION BIO INC - ORDINARY SHARES - CLASS A	1	2025-03-12	Aggregated
BEAM	1	2025-03-10	Aggregated
BEAMBEAM THERAPEUTICS INC	1	2025-03-10	Aggregated
INAB	3	2025-02-11	Aggregated
OKUR	1	2025-01-28	Aggregated
OKURONKURE THERAPEUTICS, INC. CLASS A COMMON STOCK	1	2025-01-28	Aggregated
ELTX	1	2024-10-31	Aggregated
ELTXELICIO THERAPEUTICS INC.	1	2024-10-31	Aggregated
ELVNENLIVEN THERAPEUTICS INC	1	2024-10-31	Aggregated
ORICORIC PHARMACEUTICALS INC	1	2024-10-31	Aggregated
EDITEDITAS MEDICINE INC	1	2024-09-17	Aggregated
ACET	1	2024-09-11	Aggregated
ACETADICET BIO INC	1	2024-09-11	Aggregated
CRVOCERVOMED INC	1	2024-05-29	Aggregated
BOLT	1	2024-05-15	Aggregated
CGEMCULLINAN THERAPEUTICS INC	1	2024-04-17	Aggregated
JANXJANUX THERAPEUTICS INC	1	2024-04-16	Aggregated
MNPRMONOPAR THERAPEUTICS INC	1	2024-04-11	Aggregated
INABIN8BIO INC	1	2024-03-13	Aggregated
ONCYONCOLYTICS BIOTECH, INC.	1	2023-05-24	Aggregated
COEPCOEPTIS THERAPEUTICS HOLDINGS INC	1	2023-04-19	Aggregated
HCWBHCW BIOLOGICS INC	1	2022-11-08	Aggregated
RAINRAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. CLASS A COMMON STOCK	1	2022-06-23	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.